Effectiveness of tetramethylpyrazine nitrone in amyotrophic lateral sclerosis: A randomized clinical trial
Xiaolu Liu(National University of Defense Technology), Dongsheng Fan(King University), Xi Cheng(Jiangsu Province Hospital), Xusheng Huang(Chinese PLA General Hospital), Jingxia Dang(First Affiliated Hospital of Xi'an Jiaotong University), Hongfen Wang(Chinese PLA General Hospital), Rui Jia(First Affiliated Hospital of Xi'an Jiaotong University), Qi Niu(Jiangsu Province Hospital), Zhang‐Yu Zou(Jiangxi University of Science and Technology), Huifang Shang(Sichuan University), Xiaoli Yao(Second Military Medical University), Honglin Feng(Harbin Medical University), Sheng Chen(Fujian Medical University), Min Zhang(Harbin Medical University), Shuyu Wang(Harbin Medical University), Qi Liu(Columbia University Irving Medical Center), Yang Liu(Fudan University), Yaling Liu(Kaohsiung Veterans General Hospital), Hong‐Fu Li(Second Affiliated Hospital of Zhejiang University), Qianqian Wei(Sichuan University), Zhiying Wu(Second Affiliated Hospital of Zhejiang University), Ling Lian(Sun Yat-sen University)
Cited by 0
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing
|Genome Medicine|2019|537
Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis
|Journal of Neurology|2019|315